Valid for Submission
D57.459 is a billable diagnosis code used to specify a medical diagnosis of sickle-cell thalassemia beta plus with crisis, unspecified. The code D57.459 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
Unspecified diagnosis codes like D57.459 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D57.459:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- HbS-beta plus with crisis with unspecified complication
- Sickle-cell beta plus with crisis with unspecified complication
- Sickle-cell thalassemia beta plus with (painful) crisis NOS
- Sickle-cell thalassemia beta plus with vasoocclusive pain NOS
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D57.459 are found in the index:
D57459 replaces the following previously assigned ICD-10 code(s):